2024 |
Argen X SE - ADR
|
Independent Director |
559.7 K |
-11.9 % |
2024 |
Denali Therapeutics Inc
|
Director |
- |
- |
2024 |
Guardant Health Inc
|
Independent Director |
- |
- |
2024 |
Pliant Therapeutics Inc
|
Independent Director |
- |
- |
2023 |
Argen X SE - ADR
|
Independent Director |
635.7 K |
- |
2023 |
Guardant Health Inc
|
Independent Director |
425.2 K |
- |
2023 |
Denali Therapeutics Inc
|
Director |
419.4 K |
1297.1 % |
2022 |
Gritstone Bio Inc
|
Independent Director |
87.3 K |
-50.6 % |
2022 |
Denali Therapeutics Inc
|
Director |
30.0 K |
- |
2022 |
Guardant Health Inc
|
Independent Director |
- |
- |
2022 |
Argen X SE - ADR
|
Independent Director |
- |
- |
2021 |
Gritstone Bio Inc
|
Independent Director |
176.7 K |
62.0 % |
2021 |
Corvus Pharmaceuticals Inc
|
Independent Director |
- |
- |
2020 |
Gritstone Bio Inc
|
Independent Director |
109.1 K |
-6.7 % |
2020 |
Corvus Pharmaceuticals Inc
|
Independent Director |
106.5 K |
18.9 % |
2019 |
Gritstone Bio Inc
|
Independent Director |
116.9 K |
-7.0 % |
2019 |
Corvus Pharmaceuticals Inc
|
Independent Director |
89.6 K |
-51.9 % |
2018 |
Corvus Pharmaceuticals Inc
|
Independent Director |
186.0 K |
20.3 % |
2018 |
Gritstone Bio Inc
|
Independent Director |
125.8 K |
- |
2017 |
Corvus Pharmaceuticals Inc
|
Independent Director |
154.6 K |
-56.3 % |
2017 |
Gritstone Bio Inc
|
Independent Director |
- |
- |
2016 |
Corvus Pharmaceuticals Inc
|
Independent Director |
354.1 K |
- |
2015 |
Corvus Pharmaceuticals Inc
|
Independent Director |
- |
- |